Attovia Therapeutics, Inc. (ATTO)
Nasdaq: ATTO · CIK 0002058707 · United States
Every official Attovia Therapeutics, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open ATTO filings
Attovia Therapeutics, Inc. documents
- Attovia Therapeutics, Inc. 10-K 2026ATTO 10-K 2026: annual report for fiscal 2026
- Attovia Therapeutics, Inc. 10-K 2025ATTO 10-K 2025: annual report for fiscal 2025
- Attovia Therapeutics, Inc. 10-K 2024ATTO 10-K 2024: annual report for fiscal 2024
- Attovia Therapeutics, Inc. 10-K 2023ATTO 10-K 2023: annual report for fiscal 2023
- Attovia Therapeutics, Inc. 10-K 2022ATTO 10-K 2022: annual report for fiscal 2022
- Attovia Therapeutics, Inc. 10-Q 2026ATTO 10-Q 2026: quarterly report for fiscal 2026
- Attovia Therapeutics, Inc. 10-Q 2025ATTO 10-Q 2025: quarterly report for fiscal 2025
- Attovia Therapeutics, Inc. 10-Q 2024ATTO 10-Q 2024: quarterly report for fiscal 2024
- Attovia Therapeutics, Inc. 10-Q 2023ATTO 10-Q 2023: quarterly report for fiscal 2023
- Attovia Therapeutics, Inc. 10-Q 2022ATTO 10-Q 2022: quarterly report for fiscal 2022
- Attovia Therapeutics, Inc. 8-K 2026ATTO 8-K 2026: current report for fiscal 2026
- Attovia Therapeutics, Inc. 8-K 2025ATTO 8-K 2025: current report for fiscal 2025
- Attovia Therapeutics, Inc. 8-K 2024ATTO 8-K 2024: current report for fiscal 2024
- Attovia Therapeutics, Inc. 8-K 2023ATTO 8-K 2023: current report for fiscal 2023
- Attovia Therapeutics, Inc. 8-K 2022ATTO 8-K 2022: current report for fiscal 2022
- Attovia Therapeutics, Inc. DEF 14A 2026ATTO DEF 14A 2026: proxy statement for fiscal 2026
- Attovia Therapeutics, Inc. DEF 14A 2025ATTO DEF 14A 2025: proxy statement for fiscal 2025
- Attovia Therapeutics, Inc. DEF 14A 2024ATTO DEF 14A 2024: proxy statement for fiscal 2024
- Attovia Therapeutics, Inc. DEF 14A 2023ATTO DEF 14A 2023: proxy statement for fiscal 2023
- Attovia Therapeutics, Inc. DEF 14A 2022ATTO DEF 14A 2022: proxy statement for fiscal 2022
- Attovia Therapeutics, Inc. Form 4 2026ATTO Form 4 2026: insider trading filing for fiscal 2026
- Attovia Therapeutics, Inc. Form 4 2025ATTO Form 4 2025: insider trading filing for fiscal 2025
- Attovia Therapeutics, Inc. Form 4 2024ATTO Form 4 2024: insider trading filing for fiscal 2024
- Attovia Therapeutics, Inc. Form 4 2023ATTO Form 4 2023: insider trading filing for fiscal 2023
- Attovia Therapeutics, Inc. Form 4 2022ATTO Form 4 2022: insider trading filing for fiscal 2022
- Attovia Therapeutics, Inc. S-1 2026ATTO S-1 2026: registration statement for fiscal 2026
- Attovia Therapeutics, Inc. S-1 2025ATTO S-1 2025: registration statement for fiscal 2025
- Attovia Therapeutics, Inc. S-1 2024ATTO S-1 2024: registration statement for fiscal 2024
- Attovia Therapeutics, Inc. S-1 2023ATTO S-1 2023: registration statement for fiscal 2023
- Attovia Therapeutics, Inc. S-1 2022ATTO S-1 2022: registration statement for fiscal 2022
- Attovia Therapeutics, Inc. 13F 2026ATTO 13F 2026: institutional holdings for fiscal 2026
- Attovia Therapeutics, Inc. 13F 2025ATTO 13F 2025: institutional holdings for fiscal 2025
- Attovia Therapeutics, Inc. 13F 2024ATTO 13F 2024: institutional holdings for fiscal 2024
- Attovia Therapeutics, Inc. 13F 2023ATTO 13F 2023: institutional holdings for fiscal 2023
- Attovia Therapeutics, Inc. 13F 2022ATTO 13F 2022: institutional holdings for fiscal 2022
More companies